No deaths, ~80 percent drop in hospitalization compared to the placebo group.
Womp, womp: Efficacy of Merck’s Thor-inspired COVID pill crumbles, vexing experts
FDA advisers voted 13-to-10 in favor of authorization given risks and modest benefits.
No deaths, ~80 percent drop in hospitalization compared to the placebo group.
FDA advisers voted 13-to-10 in favor of authorization given risks and modest benefits.